Wobble Genomics Appoints of Dr. Dietrich A. Stephan as Chairman of the BOD
Wobble Genomics, a biotechnology company working to improve outcomes in cancer through better diagnosis and therapy selection, via a novel ultra-sensitive cell-free RNA (cfRNA) liquid...